Buprenorphine is detectable in urine for roughly 3 days after the last dose, though the exact window varies by test type, formulation, and individual metabolism. In blood, the drug’s average elimination half-life is about 42 hours, meaning it takes several days for your body to fully clear it. But “how long it stays” depends heavily on what you mean: are you wondering about a drug test, how long the effects last, or when it leaves your bloodstream entirely?
Half-Life and How Your Body Clears It
Buprenorphine doesn’t leave your system in one clean sweep. It follows a multi-phase process. The drug redistributes from your blood into tissues quickly (within about 1.4 hours), then clears more slowly over the next several hours. The final, slowest phase of elimination has a half-life of roughly 16.5 hours for the parent drug, though the overall mean terminal elimination half-life is about 42 hours.
Your liver breaks buprenorphine down into an active metabolite called norbuprenorphine, which clears even more slowly, with an average half-life of 57 hours. Since it takes about five half-lives for a substance to be considered fully eliminated, buprenorphine itself is mostly gone from your blood within 8 to 9 days, while norbuprenorphine can linger for nearly 12 days.
Detection Windows by Test Type
Different tests pick up buprenorphine for different lengths of time. Here’s what to expect:
- Urine: Approximately 3 days after your last dose. This is the most common testing method for buprenorphine.
- Oral fluid (saliva): 1 to 5 days, depending on dose and frequency of use.
- Hair: Up to about 90 days. Hair testing captures a much longer history of drug exposure and is typically reserved for legal or retrospective purposes rather than routine monitoring.
Standard workplace drug panels (the typical 5-panel or even 10-panel tests) often do not screen for buprenorphine at all. It requires a specific immunoassay designed to detect buprenorphine and norbuprenorphine. If your concern is about a drug test, the type of panel being used matters as much as the detection window.
Monthly Injections Stay Much Longer
If you receive a monthly extended-release injection rather than a daily sublingual tablet or film, the timeline changes dramatically. The injection creates a small depot under the skin that slowly releases buprenorphine over weeks. The apparent half-life of this formulation ranges from 43 to 60 days, compared to about 42 hours for sublingual versions.
After reaching steady state (which takes about 4 to 6 months of regular injections), stopping the medication doesn’t mean quick clearance. Buprenorphine can remain at detectable levels in blood for 12 months or longer after the last injection. Therapeutic concentrations, meaning levels high enough to have a clinical effect, persist for 2 to 5 months on average depending on the dose. This is by design: it provides a buffer against relapse and withdrawal if someone misses an appointment or decides to discontinue.
What Slows Elimination Down
Your liver does the heavy lifting when it comes to processing buprenorphine, using a specific enzyme system called CYP3A4. Anything that affects liver function or this enzyme pathway can change how long the drug stays in your body.
Liver impairment has the most significant impact. People with moderate liver disease experience 2 to 3 times the drug exposure compared to people with normal liver function. Severe liver impairment produces a similar increase. This means the drug lingers longer at higher concentrations, which raises the risk of side effects. If you have liver disease and take buprenorphine, your prescriber will likely adjust your dose accordingly.
Certain medications, particularly some HIV antiretrovirals, can speed up CYP3A4 activity and reduce buprenorphine levels in the blood. Interestingly, this doesn’t always trigger withdrawal symptoms, likely because buprenorphine binds so tightly to opioid receptors and releases so slowly that even lower blood levels can maintain its effects. Other factors that influence clearance speed include body weight, age, kidney function, and how long you’ve been taking the medication. Chronic use leads to accumulation in tissues, which extends the overall elimination timeline compared to a single dose.
Single Dose vs. Regular Use
Someone who takes a single dose of buprenorphine will clear it from their system faster than someone who has been taking it daily for months. With repeated dosing, the drug builds up in fat tissue and other compartments throughout the body. These stores release buprenorphine back into the bloodstream gradually, extending both the effects and the detection window. A person on stable daily dosing might test positive in urine for several days beyond the typical 3-day window, while a one-time user would likely clear it within that timeframe.
The norbuprenorphine metabolite complicates this further. Many drug tests look for norbuprenorphine in addition to the parent drug, and since it has a longer half-life, it can push the detection window out by a day or two beyond what the parent compound alone would produce.